Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Medpace Holdings, Inc. - Common Stock (NQ:MEDP)

565.14 -3.71 (-0.65%)
Streaming Delayed Price Updated: 3:00 PM EST, Dec 31, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Medpace Holdings, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9 10 11 Next >
News headline image
2 Profitable Stocks to Keep an Eye On and 1 We Find Risky
While profitability is essential, it doesn’t guarantee long-term success. Some companies that rest on their margins will lose ground as competition intensifies - as Jeff Bezos said, "Your margin is my... 
Via StockStory
News headline image
1 Volatile Stock to Target This Week and 2 We Turn Down
Market swings can be tough to stomach, and volatile stocks often experience exaggerated moves in both directions. While many thrive during risk-on environments, many also struggle to maintain investor... 
Via StockStory
News headline image
Q3 Rundown: Azenta (NASDAQ:AZTA) Vs Other Drug Development Inputs & Services Stocks
As the Q3 earnings season wraps, let’s dig into this quarter’s best and worst performers in the drug development inputs & services industry, including Azenta (NASDAQ:AZTA) and its peers. 
Via StockStory
News headline image
Medpace (MEDP) Q3 2025 Earnings Call Transcript ↗
Medpace (MEDP) Q3 2025 Earnings Call Transcript 
Via The Motley Fool
Topics Earnings
News headline image
Medpace (NASDAQ:MEDP): Strongest Q3 Results from the Drug Development Inputs & Services Group
As the Q3 earnings season wraps, let’s dig into this quarter’s best and worst performers in the drug development inputs & services industry, including Medpace (NASDAQ:MEDP) and its peers. 
Via StockStory
News headline image
BrightSpring Health Services, 10x Genomics, QuidelOrtho, Medpace, and Fortrea Shares Are Soaring, What You Need To Know
A number of stocks jumped in the afternoon session after reports revealed the Trump administration considered extending the Affordable Care Act (ACA) subsidies. These subsidies, which are government... 
Via StockStory
Topics Economy Government
News headline image
MEDPACE HOLDINGS INC (NASDAQ:MEDP) Shows Strong Growth and Momentum Alignment ↗
MEDP stock shows strong technical momentum and accelerating earnings growth, fitting a proven strategy for finding leading growth stocks. 
Via Chartmill
News headline image
6 Healthcare Stocks With Strong Upward Momentum ↗
 
Via Benzinga
News headline image
2 Mooning Stocks to Research Further and 1 We Question
The stocks featured in this article have all approached their 52-week highs. When these price levels hit, it typically signals strong business execution, positive market sentiment, or significant... 
Via StockStory
Topics Economy
News headline image
Drug Development Inputs & Services Stocks Q3 Results: Benchmarking UFP Technologies (NASDAQ:UFPT)
As the Q3 earnings season wraps, let’s dig into this quarter’s best and worst performers in the drug development inputs & services industry, including UFP Technologies (NASDAQ:UFPT) and its peers. 
Via StockStory
News headline image
Q3 Earnings Highs And Lows: IQVIA (NYSE:IQV) Vs The Rest Of The Drug Development Inputs & Services Stocks
As the Q3 earnings season comes to a close, it’s time to take stock of this quarter’s best and worst performers in the drug development inputs & services industry, including IQVIA (NYSE:IQV) and its... 
Via StockStory
News headline image
Drug Development Inputs & Services Stocks Q3 Recap: Benchmarking Repligen (NASDAQ:RGEN)
Earnings results often indicate what direction a company will take in the months ahead. With Q3 behind us, let’s have a look at Repligen (NASDAQ:RGEN) and its peers. 
Via StockStory
News headline image
1 Mid-Cap Stock to Target This Week and 2 We Ignore
Mid-cap stocks often strike the right balance between having proven business models and market opportunities that can support $100 billion corporations. However, they face intense competition from... 
Via StockStory
News headline image
3 Cash-Heavy Stocks Worth Your Attention
In a world where many businesses have shaky balance sheets, some have ignored the crowd and exercised prudence. These cash-heavy companies shine bright for their financial discipline, resilience, and... 
Via StockStory
News headline image
5 Revealing Analyst Questions From Medpace’s Q3 Earnings Call
Medpace’s third quarter results were well received by the market, driven by broad-based revenue growth and robust net new business awards. Management credited strong demand across therapeutic... 
Via StockStory
Topics Earnings
News headline image
8 Analysts Assess Medpace Hldgs: What You Need To Know ↗
 
Via Benzinga
News headline image
Medpace Soars: AI and Data Analytics Propel Clinical Trial Giant to Record Heights
Medpace Holdings, Inc. (NASDAQ: MEDP), a leading global contract research organization (CRO), has been experiencing an unprecedented surge in its stock value, reaching an all-time high of $543.90 on... 
Via TokenRing AI
Topics Artificial Intelligence
News headline image
Why Medpace Popped 13% This Week ↗
The biopharmaceutical processor posted another strong earnings result for the third quarter. 
Via The Motley Fool
News headline image
Medpace Analysts Increase Their Forecasts After Upbeat Q3 Earnings ↗
 
Via Benzinga
News headline image
MEDP Q3 Deep Dive: Broad-Based Growth and Strong Pipeline Fuel Upbeat Outlook
Clinical research company Medpace Holdings (NASDAQ:MEDP) reported revenue ahead of Wall Street’s expectations in Q3 CY2025, with sales up 23.7% year on year to $659.9 million. The company’s full-year... 
Via StockStory
News headline image
Medpace's Q3 Earnings Beat Reflects Robust Growth And Large New Wins ↗
Medpace shares climb as Q3 earnings and revenue top estimates, driven by strong bookings, rising backlog, and an upbeat 2025 guidance. 
Via Benzinga
Topics Earnings
News headline image
Las Vegas Sands Posts Upbeat Q3 Results, Joins Garrett Motion, LendingClub, Dow, Hexcel And Other Big Stocks Moving Higher On Thursday ↗
 
Via Benzinga
Topics Stocks
News headline image
12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗
 
Via Benzinga
News headline image
Stock Market Today: Dow Jones, Nasdaq Futures Tumble Amid US-China Trade Tensions—Tesla, IBM, American Airlines In Focus ↗
U.S. stock futures were swinging on Thursday following Wednesday’s declines. Futures of major benchmark indices were lower. 
Via Benzinga
Topics Stocks
News headline image
MEDPACE HOLDINGS INC (NASDAQ:MEDP) Emerges as a Top Growth and Momentum Pick ↗
MEDP Holdings stock shows strong technical and fundamental growth momentum, meeting strict trend-following criteria for a powerful setup. 
Via Chartmill
News headline image
Medpace Rockets On 'Another Strong Q' That Includes A Guidance Hike ↗
Medpace stock rocketed late Wednesday on "another strong Q," that included double-digit sales and profit growth. 
Via Investor's Business Daily
News headline image
12 Health Care Stocks Moving In Wednesday's After-Market Session ↗
 
Via Benzinga
News headline image
Medpace Holdings Inc (NASDAQ:MEDP) Tops Q3 2025 Earnings and Revenue Estimates ↗
Medpace (MEDP) Q3 2025 earnings beat analyst forecasts with strong revenue and EPS growth. The CRO also reported robust bookings and raised its full-year guidance. 
Via Chartmill
Topics Earnings
News headline image
Medpace (NASDAQ:MEDP) Beats Q3 Sales Expectations, Stock Jumps 18.5%
Clinical research company Medpace Holdings (NASDAQ:MEDP) reported Q3 CY2025 results exceeding the market’s revenue expectations, with sales up 23.7% year on year to $659.9 million. The company’s... 
Via StockStory
News headline image
Which stocks are moving after the closing bell on Wednesday? ↗
Discover the top movers in Wednesday's after-hours session and stay informed about the post-market dynamics. 
Via Chartmill
< Previous 1 2 3 4 5 6 7 8 9 10 11 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.